Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.

Kudahetti, Sakunthala C; Fisher, Gabrielle; Ambroisine, Laurence; Prowse, David; Kattan, Michael W; Foster, Christopher S; Møller, Henrik; Oliver, Tim; Fletcher, Anne; Cooper, Colin; +5 more... Reuter, Victor; Scardino, Peter; Cuzick, Jack; Berney, Daniel M; Transatlantic Prostate Group; (2010) Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology, 42 (6). pp. 519-523. ISSN 0031-3025 DOI: https://doi.org/10.3109/00313025.2010.508788

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3109/00313025.2010.508788

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar